The U.S. Food and Drug Administration approved Italy-based Cassiopea SpA’s acne treatment Winlevi (clascoterone cream 1%).

Eli Lilly and Co. is buying skin disease specialist Dermira Inc. for about $1.1 billion in cash, bolstering the Indianapolis-based drug manufacturer’s arsenal with an experimental therapy for the skin condition atopic dermatitis.

Johnson & Johnson Innovation kick started 2018 by striking collaborative agreements with 15 different organizations and companies to address areas of high unmet medical need in neuroscience, oncology and other areas.